This is a phase III, double-blind placebo controlled study among 12 years and older patients with proven Herpes Simplex Encephalitis (HSE) currently completed or being treated with IV Acyclovir in order to determine if treatment with 2g of Valacyclovir given 3x/day by mouth for 90 days will be ....